New Owner
Celldex Therapeutics - Kolltan Pharmaceuticals
Celldex Therapeutics acquires Kolltan Pharmaceuticals
Announced: November 01, 2016
Type: Acquisition
Terms: Stock
Status: Complete
Amount: $ 235,000,000
Celldex Therapeutics Other Acquisitions
Add Acquisition| Date | Acquired | Amount |
|---|---|---|
| Oct 01, 2009 |
|
Undisclosed amount |
| Oct 12, 2005 |
|
Undisclosed amount |
